This new video series from CVIR features engaging discussions on the latest trends and important issues in IR. The series features CVIR Editor for Public Affairs, Miltiadis Krokidis interviewing different CVIR authors to discuss their articles, how their research began, and how it affects the field as a whole and all working in it.
Do you want to hear about the newest issues in IR, the biggest studies going on in the field, and learn more about concerns that affect interventionists? Then let's Krok about it!
Some of the topics covered include:
Dr. Mosconi covered the systematic review comparing transarterial chemoembolization and radioembolization for unresectable intrahepatic cholangiocarcinoma. She outlines how the patients for the study were determined, as well as the outcomes of study in more detail. Although radioembolization showed more favourable outcomes, how much was due to patient characteristics?
Watch the full video here to find out!
In the latest video, Prof. Stefan Müller-Hülsbeck discussed some of the aspects of the IMPERIAL randomized control trial, comparing the Eluvia stent and the Zilver PTX stent. He discussed amendments to the study, study outcomes, and what characteristics of the devices may explain these results.
Read the full article here for more details!
Prof. Gerard Goh spoke to us about the practical applications of artificial intelligence in the field of interventional radiology. He highlighted how it can be used ahead of procedures, such as in patient selection, as well as during procedures to guide operators, and can even be applied in the follow-up, by highlighting which patients may be at greater risk for tumour recurrence.
If you want to know more about how to get started, check out the article Prime Time for Artificial Intelligence in Interventional Radiology!
Dr. Pedersoli spoke to us about the article Stent Graft Placement by Pseudoaneurysm of the Hepatic Arteries: Efficacy and Patency Rate in Follow-up.
He and Dr. Krokidis discussed the study, including patency, thrombosis, and collaterisation. Check it out and read the full article for more information!
Dr. Shankar Rajeswaran gave us an update on this innovative procedure combining chemical sclerosis and synthetic grafting for paediatric patients with unicameral bone cysts. This procedure is shorter than open surgery, has lower recurrence rates, and allows patients to get back to full activity at a mean of 2.0 months post procedure!
If you want to know more, check out the full article Minimally Invasive Treatment for Unicameral Bone Cysts with Chemical Sclerosis and Bone Graft Substitute: A Preliminary Report, published in CVIR.
Dr. Krokidis spoke with Dr. Sara Silberstein about her paper Ethics in Interventional Radiology: A Case-Based Primer.
In the interview, they discuss whether IR is more susceptible to ethical dilemmas due to its minimally invasive nature, what role culture plays, and what IRs can do to protect themselves from liability.